Zhengxia Wang

Zhengxia Wang

Auto-generated profile, based on publicly available information

Zhengxia Wang

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
ZWZhengxia Wang
Zhengxia Wang
NJNingfei Ji
Ningfei Ji
ZCZhongqi Chen
Zhongqi Chen
ZSZhixiao Sun
Zhixiao Sun
CWChaojie Wu
Chaojie Wu
MZMingshun Zhang
Mingshun Zhang
Wang Z, et al. Allergy Asthma Immunol Res. 2020 Sep;12(5):859-876. https://doi.org/10.4168/aair.2020.12.5.859

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
NJNingfei Ji
Ningfei Ji
ZCZhongqi Chen
Zhongqi Chen
ZWZhengxia Wang
Zhengxia Wang
WSWei Sun
Wei Sun
QYQi Yuan
Qi Yuan
MHMao Huang
Mao Huang
Ji N, et al. Allergy Asthma Immunol Res. 2024 Jan;16(1):71-90. https://doi.org/10.4168/aair.2024.16.1.71

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
QYQi Yuan
Qi Yuan
XJXinyu Jia
Xinyu Jia
MWMin Wang
Min Wang
ZCZhongqi Chen
Zhongqi Chen
TXTingting Xu
Tingting Xu
NJNingfei Ji
Ningfei Ji
Yuan Q, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):422-433. https://doi.org/10.4168/aair.2024.16.4.422

13 March 2024 in Clinical and Translational Science
Verified
Journal Article
Open access
XJXinyu Jia
Xinyu Jia
JJJingxian Jiang
Jingxian Jiang
CYChen Yang
Chen Yang
SZSujuan Zhang
Sujuan Zhang
JWJingjing Wu
Jingjing Wu
NJNingfei Ji
Ningfei Ji
This study examined the levels of soluble CD146 (sCD146) in plasma samples from patients with chronic obstructive pulmonary disease (COPD) and assessed the relationship between sCD146 and the severity of COPD. A total of 97 COPD patients were recruited from 20 medical centers in Jiangsu, China, including 13 stable subjects and 84 exacerbated subjects. The plasma sCD146 level in exacerbated subjects (28.77 ± 10.80 ng/mL) was significantly lower than that in stable subjects (38.84 ± 15.00 ng/mL). In the high sCD146 group, the proportion of subjects with modified Medical Research Council (mMRC) scores of 0–1 was higher, the proportion of subjects with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 4 was lower, and the proportion of subjects with ≥1 hospitalizations in the past year was lower. The plasma sCD146 level was negatively correlated with the COPD Assessment Test (CAT) score (r = −0.2664, p = 0.0087). Logistic regression analysis showed that sCD146 was an independent risk factor for acute exacerbation of COPD (AECOPD). Receiver operating characteristic (ROC) analysis suggested that sCD146 combined with sex, age, pulmonary function, and acute exacerbations in the past year had clinical value for the accurate identification of AECOPD, with an area under the ROC curve (AUC) of 0.908 (95% CI: 0.810–1.000, p < 0.001). In addition, there was a significant negative correlation between plasma sCD146 and S100A9 (r = −0.3939, p < 0.001).